Recent Finacing
Recent Raise
Monte Rosa Therapeutics builds small-molecule molecular glues that reprogram ubiquitin ligases to degrade disease-driving proteins, combining chemical libraries, proteomics, structural biology, machine-learning target selection and computational chemistry.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
